Abstract Submission Guidelines
AAI invites members and nonmembers to submit abstracts of original research for consideration for presentation at IMMUNOLOGY2027™. Review the abstract submission guidelines carefully before beginning your submission. By submitting an abstract, you agree to the policies and requirements outlined on this page.
Important Dates
All deadlines are 11:59 PM ET unless otherwise noted
Regular Submission Period
Late-Breaking Submission Period
Major Symposium Guidance for Trainees
We are pleased to offer AAI trainee members who are graduate students or postdoctoral fellows the opportunity to present their research in IMMUNOLOGY2027™ Major Symposia. Speakers will be selected from AAI trainee member-submitted abstracts relevant to the Major Symposium topic areas.
Please use the list of IMMUNOLOGY2027™ Major Symposium topics below as reference for selecting session(s) that best match the topic of your abstract. Your selection will help the Programming Chairs and Major Symposium Chairs identify abstracts that are relevant to each session.
Major Symposia Topics:
- Allergic responses and T2 inflammation
- Computational and systems immunology
- Innate immune sensors/inflammation
- Immune engineering
- Immunopeptidomics, antigen presentation, and immune modulation
- Inborn errors of immunity
- Multifunctional role of B cells in protection and pathology
Before You Submit
Both AAI members and nonmembers are invited to submit abstracts. An AAI account is required to submit an abstract. If you do not already have an AAI account, you will need to create one before accessing the abstract submission system. Please visit https://members.aai.org/ to create an account.
There is no limit to the number of abstracts you can submit, provided each submission represents distinct research. Do not submit multiple versions of the same abstract as duplicate submissions may be rejected.
Abstracts should report original research and should accurately reflect the work and results being presented. Abstracts should not be submitted if the research has already been presented at a national or international meeting unless the abstract includes substantial new findings.
During the submission process you will have the opportunity to indicate your preferred presentation format as a podium presentation or a poster. Your selection indicates your preference but does not guarantee assignment to your preferred presentation format. AAI will determine the final presentation format based on the abstract review and scheduling process.
Submission Fees
During the regular submission period AAI members receive a complimentary regular abstract submission fee. Nonmembers can submit an abstract for the applicable non-refundable nonmember fee of $145.
During the late breaking period AAI members will be required to pay the applicable non-refundable abstract submission fee of $115. Nonmembers can submit an abstract for the applicable non-refundable nonmember fee of $180.
Please Note: Submission rates are based on your membership status at the time of abstract submission. If you join AAI after submitting your abstract, the difference in fees will not be reimbursed. You can join AAI prior to submitting your abstract and the complimentary fee will immediately be available. Please do not use another AAI member’s membership number to receive the complimentary member submission fee. AAI will verify that the submitter’s information corresponds with the membership number provided. If the submitter does not match the member information provided, they will be contacted and given two weeks to either join AAI or pay the applicable nonmember submission fee. If neither action is taken within two weeks, the submission will not be accepted.
Authors and Presenting Author
The abstract submitter is the first author and the presenting author. This can not be changed once the abstract has been submitted. Please be sure you have included ALL authors and have carefully reviewed all author information before finalizing your submission, including:
- Author names and spelling
- Author order
- Institutional affiliations
- Email addresses
- Presenting author designation, where applicable
AAI will publish author names and affiliations as submitted. Please proofread all information carefully before submitting.
Abstract Content
For IMMUNOLOGY2027™, abstracts will be submitted using the following structured sections:
Abstract Title
- No quotations or all UPPERCASE letters. Up to 200 characters
- Titles should be concise, descriptive, and accurately reflect the research.
Abstract Body
- Up to 2000 characters, including spaces and punctuation.
- Enter or cut-and-paste the body of your abstract from a Word or plain text document into the appropriate box.
- Be sure to double check the appearance of any special characters/symbols used.
- The abstract body should include
- A sentence stating the study objective (unless given in the title).
- A statement of methods
- A summary of results
- A statement of conclusions. Stating “the results will be discussed” is not sufficient.
- Tables and figures are not permitted.
- Do not repeat the abstract title in this section
Topic Categories
- Each abstract must be assigned by the submitter to the topic category that best represents the research.
- Please review the IMMUNOLOGY2027™ Abstract Topics before submitting your abstract and select the category that most closely aligns with your work.
- AAI reviewers may determine that an abstract is better suited to another category and may move the submission accordingly.
Keywords
You will be asked to provide keywords to help identify and search for your abstract. Choose keywords that accurately describe the research, methods, disease areas, biological systems, or other important aspects of the work.
Abbreviations
Please refer to the AAI standard abbreviations guide for how to abbreviate scientific terms in your abstract.
Greek Letters
The abstract submission system does not allow Greek letters to be added from a keyboard or using copy/paste. Please replace Greek letters with the corresponding HTML code found in our helpful cheat sheet.
Funding and Disclosures
All applicable funding sources must be disclosed during the submission process. Authors must also provide any required conflict-of-interest disclosures. Please ensure that all funding and disclosure information is complete and accurate.
Tips for Preparing Your Abstract
Before submitting, please make sure that:
- The title accurately reflects your research.
- The abstract clearly states the research question or objective, is described sufficiently to understand the approach, results include specific findings and data, and conclusions are supported by the results.
- Abbreviations are defined at first use.
- All author names and affiliations are spelled correctly.
- Authors are listed in the correct order.
- Tables and figures are not permitted.
- Funding information is complete.
- Conflict-of-interest information is complete.
- The appropriate topic category has been selected.
- The abstract has been carefully proofread.
- AAI will publish accepted abstracts as submitted and does not copy edit abstracts. Please review your submission carefully before finalizing it.
Presentation Requirements
Submission of an abstract constitutes a commitment to present the research if the abstract is accepted. Presenting authors are required to register for IMMUNOLOGY2027™. Abstract submission and meeting registration are separate processes and separate fees.
If your abstract is accepted, you will receive information regarding your assigned presentation format, date, time, and location. Presenting authors are responsible for ensuring that they are available to present at their assigned time. Failure to present an accepted abstract as assigned may result in withdrawal of the abstract from publication.
Abstract Review
All submitted abstracts are reviewed by experts in the appropriate scientific areas. Abstracts are evaluated based on factors that may include:
- Originality and innovation
- Clarity and organization
- Relevance to the meeting
- Scientific rigor and appropriateness of methods
- Quality and significance of the results
- Contribution to the field
AAI reserves the right to determine the final presentation format and scheduling of accepted abstracts.
Revisions After Submission
You may make changes to your abstract through the submission system until the submission deadline. No revisions will be accepted after the submission deadline, except where specifically authorized by AAI. Please retain a copy of your final submission for your records.
Withdrawing Your Submission
The submitting author may withdraw an abstract through the submission system until the deadline established by AAI. After the withdrawal deadline, please make withdrawal requests by email to meetings@aai.org. Withdrawal requests must be submitted to AAI and may require approval. All co-authors should be included in communications regarding withdrawal. Please include the following information with any withdrawal request:
- Abstract number
- Abstract title
- Submitting/presenting author
- Reason for withdrawal
Embargo and Publication
Abstracts accepted for IMMUNOLOGY2027™ are considered official communications of the meeting. Abstracts must comply with AAI’s embargo and publication policies. Abstracts should be based on results that have not been previously published and are not expected to be published before the meeting, unless the publication occurs after the applicable withdrawal deadline.
Accepted abstracts will be published as part of the official meeting abstract publication and may also be made available through AAI meeting resources and the official meeting app. Withdrawn or non-presented abstracts may be excluded from publication.
For complete information, please review the IMMUNOLOGY2027™ Embargo and Copyright Policy.
Copyright and Permissions
All accepted IMMUNOLOGY2027™ abstracts will be published as an online supplement to The Journal of Immunology within 90 days following the end of the meeting and will remain permanently archived. Abstracts will also be available in the official IMMUNOLOGY2027™ App (for iPhone and Android) approximately 30 days prior to the meeting opening. Withdrawn or non-presented abstracts will be excluded from both the meeting app and the online journal supplement.
In order to publish the abstract in The Journal of Immunology, we require that you grant to us an exclusive license to certain rights in the article as further described below:
You hereby grant to us an exclusive worldwide license for the legal term of copyright:
- to publish the Article in the Journal, and to distribute, sell, transmit, and/or communicate to the public and otherwise use the Article in whole or in part in the Journal, on its own, or with other material or works, in any language or medium whether now known or hereafter devised;
- to create, publish and distribute translations and abstracts of the Article; and
- to authorize or grant licenses to third parties to do any of the above.
However, you will have permission to reuse the Article in accordance with Oxford University Press’s policies.
Guidance on citing an IMMUNOLOGY2027™ abstract
The following are examples of the suggested style for citing IMMUNOLOGY2027™ abstracts:
After an abstract has been accepted but before it is posted online as part of The Journal of Immunology website/AAI Annual Meeting archive:
Kuhns, M.S., M. Lee, C. Glassman, N.R. Deshpande, and H. Parrish. 2015. Evidence for a pivot upon TCT engagement. Presented at: IMMUNOLOGY 2015™, Annual Meeting of The American Association of Immunologists, May 8 – 12, The American Association of Immunologists, Inc., New Orleans, Abstract 61.1
After the abstract has been posted online as part of The Journal of Immunology website/AAI Annual Meeting archive:
Kuhns, M.S., M. Lee, C. Glassman, N.R. Deshpande, and H. Parrish. 2015. Evidence for a pivot upon TCT engagement. J. Immunol. 194: 61.1 (Abstr.)
Research Ethics
Research involving human subjects or animals must comply with applicable ethical standards, regulations, and institutional requirements. By submitting an abstract, authors confirm that the research was conducted in accordance with applicable requirements.
Audio, Video, and Photography
By submitting an abstract and participating in IMMUNOLOGY2027™, presenting authors acknowledge AAI’s policies regarding photography, audio/video recording, and use of presentation materials. For complete information, please review the IMMUNOLOGY2027™ Meeting Policies (coming soon).
Technical Support
For technical assistance with the abstract submission system, please contact: meetings@aai.org. Please include your abstract number, if available, and provide a description or screenshot of the issue when possible.
Looking for more information?
Register
Learn more about the registration fees for IMMUNOLOGY2027™.
COMING SOON